Search

Displaying results 7311 - 7320 of 8573 in total
  1. Drug

    Adrixetinib

    go.drugbank.com/drugs/DB21620
    Investigational

    Adrixetinib has a monoisotopic molecular weight of 531.17 Da.

  2. Drug

    Friluglanstat

    go.drugbank.com/drugs/DB21652
    Experimental

    Friluglanstat has a monoisotopic molecular weight of 516.12 Da.

  3. Drug

    Canlitinib

    go.drugbank.com/drugs/DB21656
    Experimental

    Canlitinib has a monoisotopic molecular weight of 619.21 Da.

  4. Drug

    Labuxtinib

    go.drugbank.com/drugs/DB21658
    Experimental

    Labuxtinib has a monoisotopic molecular weight of 377.13 Da.

  5. Drug

    Chlorotoxin I-131

    go.drugbank.com/drugs/DB05462
    Investigational

    The synthetic version of this peptide has been manufactured and covalently linked to iodine 131 as a means of targeting radiation to tumor cells in the treatment of brain cancer.

  6. Drug

    Amcipatricin

    go.drugbank.com/drugs/DB12333
    Investigational

    Amcipatricin has been used in trials studying the treatment of Cryptococcosis or Aspergillosis Infections. … Amcipatricin (as amcipatricin diascorbate; SPK-843) is a water-soluble partricin derivative patented by SPA Societa Prodotti Antibiotici S.p.A. and developed by Aparts and Kaken for the potential treatment

  7. Drug

    Fenspiride

    go.drugbank.com/drugs/DB08979
    Investigational

    well as for maintenance treatment of asthma. … Fenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.

  8. Drug

    Chelerythrine

    go.drugbank.com/drugs/DB17024
    Experimental

    A benzophenanthridine alkaloid evaluated as a kinase-inhibitor.[A252982]

  9. Drug

    Abexinostat

    go.drugbank.com/drugs/DB12565
    Investigational

    Abexinostat has been used in trials studying the treatment of Sarcoma, Lymphoma, Leukemia, Lymphocytic, and Hodgkin Disease, among others.

  10. Drug

    Arlocabtagene autoleucel

    go.drugbank.com/drugs/DB24024
    Investigational

    Arlocabtagene Autoleucel is under investigation in clinical trial NCT06297226 (Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or